Medtronic plc (MDT)
| Market Cap | 111.64B |
| Revenue (ttm) | 33.20B |
| Net Income (ttm) | 4.26B |
| Shares Out | 1.28B |
| EPS (ttm) | 3.27 |
| PE Ratio | 26.60 |
| Forward PE | 15.10 |
| Dividend | $2.80 (3.22%) |
| Ex-Dividend Date | Dec 27, 2024 |
| Volume | 7,687,933 |
| Open | 86.00 |
| Previous Close | 86.07 |
| Day's Range | 85.70 - 87.17 |
| 52-Week Range | 75.96 - 93.08 |
| Beta | 0.86 |
| Analysts | Hold |
| Price Target | 93.87 (+7.9%) |
| Earnings Date | Feb 18, 2025 |
About MDT
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accesso... [Read more]
Financial Performance
In 2024, Medtronic's revenue was $32.36 billion, an increase of 3.64% compared to the previous year's $31.23 billion. Earnings were $3.68 billion, a decrease of -2.18%.
Financial StatementsAnalyst Forecast
According to 16 analysts, the average rating for MDT stock is "Hold." The 12-month stock price forecast is $93.87, which is an increase of 7.90% from the latest price.
News
Medtronic plc (MDT) Q3 2025 Earnings Call Transcript
Medtronic plc (NYSE:MDT) Q3 2025 Earnings Conference Call February 18, 2025 8:00 AM ET Company Participants Ryan Weispfenning - Vice President and Head of Investor Relations Geoff Martha - Chairman a...
Medtronic Q3 Earnings: Cardiovascular And Neuroscience Drive Growth, Surgical Revenue Dips, Reaffirms Annual Forecast
Tuesday, Medtronic Plc MDT reported third-quarter 2025 sales of $8.29 billion, missing the consensus of $8.32 billion.
Medtronic credits heart-surgery-device growth as profit tops analyst estimates
Medtronic said it is “starting to see the results” of its investment in new products.
Medtronic beats quarterly profit estimates on strong heart, diabetes device sales
Medtronic beat Wall Street estimates for quarterly profit on Tuesday, on strong demand for its heart and diabetes devices.
Medtronic reports third quarter fiscal 2025 financial results
Delivering durable revenue growth with strong earnings power; strength in Pulsed Field Ablation, Pacing, Structural Heart, Diabetes, and Neuromodulation GALWAY, Ireland , Feb. 18, 2025 /PRNewswire/ --...
Medtronic: Several Reasons For Optimism Before The Upcoming Earnings Release
Medtronic: Several Reasons For Optimism Before The Upcoming Earnings Release
Retirement Strategy: 2 Dividend Aristocrats At Bargain Prices
Buying battle-tested dividend aristocrats can be a winning strategy for those seeking durable retirement income. What's even better is if they also carry strong balance sheets and are attractively val...
Here are the best performing dividend aristocrats stocks in 2025
Dividend aristocrat stocks have largely done well in the past few years. The closely-followed ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has jumped by over 133% from its lowest level in 2020.
Medtronic to announce financial results for its third quarter of fiscal year 2025
GALWAY, Ireland , Feb. 5, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fisca...
North America Balloon Sinuplasty Systems Market Outlook to 2033, with Profiles of Leading Companies Acclarent, Medtronic and Entellus Medical
Dublin, Feb. 03, 2025 (GLOBE NEWSWIRE) -- The "North America Balloon Sinuplasty Systems Market Outlook to 2033" report has been added to ResearchAndMarkets.com's offering. The comprehensive databook r...
Chart Master: Four stocks on cusp of breakout
Carter Worth, Worth Charting, gives his technical analysis on four stocks on the verge of breaking out.
Medtronic appoints Renault's exec Thierry Piéton as finance chief
Medtronic said on Monday it will appoint Renault's finance chief Thierry Piéton as its Chief Financial Officer, effective March 3.
Medtronic appoints Thierry Piéton as Chief Financial Officer
GALWAY, Ireland , Jan. 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that Thierry Piéton has been appointed Chief Financial Officer for ...
Medtronic plc (MDT) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)
Medtronic plc (NYSE:MDT) 43rd Annual J.P. Morgan Healthcare Conference Call January 13, 2025 5:15 PM ET Company Participants Geoff Martha - Chief Executive Officer Sean Salmon - EVP & President, Card...
Medtronic announces CMS national coverage analysis for Symplicity™ Spyral Renal Denervation System
National coverage analysis is the first-of-its kind for a minimally invasive, interventional treatment for high blood pressure Milestone is supported by large public health need and robust, long-term ...
Medtronic achieves CE Mark approval for BrainSense™ Adaptive deep brain stimulation and Electrode Identifier, a groundbreaking advance in personalized, sensing-enabled care for people with Parkinson's through innovative brain-computer interface technology
European approval introduces the world's only closed-loop DBS system with real-time, self-adjusting brain stimulation for people with Parkinson's disease GALWAY, Ireland , Jan. 13, 2025 /PRNewswire/ -...
Medtronic: Scoop Up This Dividend Aristocrat On Sale Now
Shares of Medtronic have lagged the S&P 500 index in the months since my previous article. The company's revenue and non-GAAP EPS grew during its fiscal Q2. Medtronic boasts an A credit rating from S&...
Kuros Biosciences USA, Inc. Announces an Exclusive Strategic Agreement with the Medtronic Spinal Division
Medtronic will act as the exclusive sales agent of MagnetOsTM for Kuros Biosciences USA, Inc. in mutually agreed upon sales territories for use in spine surgeries Kuros will work collaboratively to se...
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
GALWAY, Ireland , Jan. 6, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 43rd annual J.P. Morgan healthcare confere...
Medtronic: A Dividend Aristocrat That's Poised To Pop
Medtronic offers value and income potential with a 3.5% dividend yield, strong fundamentals, and 47 years of consecutive dividend increases. Despite recent share price underperformance, MDT shows soli...
2 Cheap Dividend Aristocrats to Buy for 2025
#Morningstar #DividendArtisocrats #StockInvesting These reliable dividend stocks look significantly undervalued today. 00:00 Introduction 00:39 Federal Realty Trust FRT 01:25 Medtronic MDT Susan Dziu...
My Best Dividend Aristocrats For January 2025
The ProShares S&P 500 Dividend Aristocrat ETF rocked a cool 4.85% gain in November, but it's giving up nearly half of its return this year in December. I present 3 strategies that can theoretically be...
Medtronic Stock Is Still A Great "Buy"
Medtronic remains a "Buy" due to its undervalued stock, recent product launches, and resolved supply chain issues, despite underperformance over the past 7 months. The company posted solid Q2 results ...
Medtronic announces cash dividend for third quarter of fiscal year 2025
GALWAY, Ireland , Dec. 5, 2024 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, December 5, 2024, approved the company's cash dividend for the third quarter of fiscal y...